封面
市场调查报告书
商品编码
1629212

葡萄糖耐受性测试市场,按产品类型、按疾病适应症、按最终用户、按国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Glucose Tolerance Test Market, By Product Type, By Disease Indication, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年,葡萄糖耐受性测试市场规模为2,692,043万美元,2024年至2032年复合年增长率为6.60%。

葡萄糖耐受性测试市场-市场动态

全球糖尿病发生率上升推动市场需求

全球糖尿病盛行率的不断上升是推动全球葡萄糖耐受性测试市场成长的主要因素。例如,预计到 2045 年,全球糖尿病发生率将从 2021 年的 5.37 亿增至 7.83 亿。方案预计将推动市场成长。然而,欠发达地区的高成本和医疗服务受限可能会阻碍市场成长。相反,深度学习和机器人技术在诊断行业的整合以及政府对糖尿病治疗和诊断研发的资助的增加预计将在预测期内为市场提供巨大的成长机会。

葡萄糖耐受性测试市场 - 关键见解

根据我们的研究分析师分享的分析,预计全球市场在预测期内(2024-2032 年)每年将以 6.60% 左右的复合年增长率成长

根据产品类型细分,预计血糖检测试剂盒将在 2023 年呈现最大市场份额

根据疾病适应症细分,2023年糖尿病低血糖为主导细分

按地区划分,北美葡萄糖耐受性测试市场是 2023 年的主要收入来源

葡萄糖耐受性测试市场-細項分析:

全球葡萄糖耐受性测试市场根据产品类型、疾病适应症、最终用户和地区进行细分。

市场依产品类型分为四大类:血糖检测套件、智慧感测器、仪表等。血糖检测试剂盒产业占市场主导地位。智慧感测器技术和无缝物联网连接的进步正在推动市场成长。

根据最终用户,市场分为两类:家庭护理环境、医院和诊所、诊断中心等。医院和诊所行业在市场中占据主导地位,并可能在预测期内保持其主导地位。这主要是由于他们处理的患者量很大,并且可以使用先进的诊断工具来进行准确、高效的葡萄糖耐受性测试。

葡萄糖耐受测试市场-地理洞察

从地理来看,该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区、中东和非洲地区。这些区域根据开展业务的国家进一步划分。

葡萄糖耐受性测试市场-竞争格局:

人们对糖尿病早期检测的认识不断增强,并付出了努力,推动了市场的发展。公司正在优先考虑策略合作,以加强研究和开发先进的诊断解决方案。为了保持竞争力,参与者正在投资尖端技术,例如数位健康集成,以实现更好的血糖监测。此外,透过併购扩大全球影响力是一个重点,因为它有助于丰富产品线并进入未开发的市场,提高整体竞争力和市场影响力。

最新进展:

2024 年 8 月,DirectSens 推出了 XpressGT RUO 套件,用于诊断妊娠糖尿病、子宫内膜异位症、胰岛素抗性和肝病等疾病。 XpressGT 与标准临床分析仪相容,只需 8 分钟即可提供结果,测量静脉血液中的 2-羟基丁酸 (2-HB) 水平,当该水平升高时,表明潜在的内分泌和代谢紊乱。

目录

第一章:葡萄糖耐受性测试市场概述

  • 研究范围
  • 市场预估年份

第 2 章:执行摘要

  • 市场片段
    • 按产品类型分類的葡萄糖耐受性测试市场片段
    • 按疾病指示分类的葡萄糖耐受性测试市场片段
    • 最终用户的葡萄糖耐受性测试市场片段
    • 按国家/地区分類的葡萄糖耐受性测试市场片段
    • 按地区分類的葡萄糖耐受性测试市场片段
  • 竞争洞察

第 3 章:葡萄糖耐受性测试主要市场趋势

  • 葡萄糖耐受性测试市场驱动因素
    • 市场驱动因素的影响分析
  • 糖耐量测试市场限制
    • 市场限制影响分析
  • 葡萄糖耐受测试市场机会
  • 葡萄糖耐受性测试市场未来趋势

第 4 章:葡萄糖耐受性测试产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章:葡萄糖耐受性测试市场:地缘政治紧张局势升级的影响

  • COVID-19 大流行的影响
  • 俄罗斯-乌克兰战争的影响
  • 中东衝突的影响

第 6 章:葡萄糖耐受性测试市场格局

  • 2023 年葡萄糖耐受性测试市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章:葡萄糖耐受性测试市场 - 按产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 血糖测试套件
    • 智慧感测器
    • 其他的

第 8 章:葡萄糖耐受性测试市场 - 按疾病适应症

  • 概述
    • 按疾病适应症分類的细分市场份额分析
    • 糖尿病低血糖
    • 反应性低血糖
    • 妊娠糖尿病
    • 其他的

第 9 章:葡萄糖耐受性测试市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 家庭护理设置
    • 医院和诊所
    • 诊断中心
    • 其他的

第 10 章:葡萄糖耐受性测试市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美葡萄糖耐受性测试主要製造商
    • 北美市场规模和预测(按国家)
    • 北美市场规模和预测(按产品类型)
    • 北美市场规模与预测(按疾病适应症)
    • 北美市场规模和预测(按最终用户)
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲葡萄糖耐受性测试主要製造商
    • 欧洲市场规模和预测(按国家)
    • 欧洲市场规模和预测(按产品类型)
    • 欧洲市场规模与预测(按疾病适应症)
    • 欧洲市场规模和预测(按最终用户)
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区葡萄糖耐受测试主要製造商
    • 亚太地区市场规模与预测(按国家)
    • 亚太地区市场规模与预测(依产品类型)
    • 亚太地区市场规模与预测(依疾病适应症)
    • 亚太地区市场规模和预测(按最终用户)
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲葡萄糖耐受测试主要製造商
    • 拉丁美洲市场规模与预测(按国家)
    • 拉丁美洲市场规模与预测(按产品类型)
    • 拉丁美洲市场规模与预测(按疾病适应症)
    • 拉丁美洲市场规模和预测(按最终用户)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲葡萄糖耐受测试主要製造商
    • 中东和非洲市场规模及预测(按国家)
    • 中东和非洲市场规模及预测(按产品类型)
    • 中东和非洲市场规模及预测(依疾病指示)
    • 中东和非洲市场规模和预测(按最终用户)
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章:主要供应商分析-葡萄糖耐受测试产业

  • 竞争仪表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Thermo Fisher Scientific Inc.
    • NIPRO
    • Medtronic
    • Trividia Health, Inc.
    • Healius Limited
    • Dexcom, Inc.
    • Penlan Healthcare Ltd.
    • Johnson & Johnson Services, Inc.
    • Quest Diagnostics Incorporated
    • Abbott
    • Laboratory Corporation of America Holdings
    • Cleveland HeartLab, Inc.
    • ARUP Laboratories
    • Merck KGaA
    • Ascensia Diabetes Care Holdings AG
    • Bayer AG
    • E-Zlab Health Services
    • LifeScan IP Holdings, LLC
    • F. Hoffman-La Roche Ltd.
    • Sanofi
    • Others

第 12 章:360 度分析师视角

第 13 章:附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4441

REPORT HIGHLIGHT

Glucose tolerance test market size was valued at USD 26,920.43 Million in 2023, expanding at a CAGR of 6.60% from 2024 to 2032.

A glucose tolerance test (GTT) is a diagnostic tool used to evaluate the body's response to sugar intake, primarily for diagnosing diabetes. It includes an oral glucose tolerance test (OGTT), where blood glucose levels are measured before and after consuming a glucose solution. High glucose levels may indicate impaired sugar absorption by body cells. A simpler version, the glucose challenge test, involves a single blood test following glucose intake.

Glucose Tolerance Test Market- Market Dynamics

Increasing rate of diabetes worldwide to propel market demand

The growing prevalence of diabetes among people across the globe is the major factor driving the growth of the global glucose tolerance test market. For instance, the global incidence of diabetes is expected to rise to 783 million by 2045, up from 537 million in 2021. Besides, increasing awareness of diabetes mellitus in densely populated regions, combined with significant investments in the design and development of large-scale diagnostic solutions, is expected to fuel market growth. However, high costs and restricted access to medical services in underdeveloped regions may hamper the market growth. On the contrary, the integration of deep learning and robotics in the diagnostic industry and increased government funding for research and development in diabetes therapeutics & diagnostics are predicted to provide massive growth opportunities for the market during the forecast period.

Glucose Tolerance Test Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.60% over the forecast period (2024-2032)

Based on product type segmentation, blood glucose test kit was predicted to show maximum market share in the year 2023

Based on disease indication segmentation, diabetes hypoglycemia was the leading segment in 2023

On the basis of region, the North America glucose tolerance test market was the leading revenue generator in 2023

Glucose Tolerance Test Market- Segmentation Analysis:

The Global Glucose Tolerance Test Market is segmented on the basis of Product Type, Disease Indication, End User, and Region.

The market is divided into four categories based on product type: blood glucose testing kit, smart sensors, meters, and others. The blood glucose testing kit sector dominates the market. Advancements in smart sensor technology and seamless IoT connectivity are driving the market growth.

The market is divided into two categories based on end user: homecare settings, hospitals & clinics, diagnostic centers, and others. The hospitals & clinics sector dominates the market and is likely to maintain its dominance during the forecast period. This is mainly due to the high patient volume they handle and the availability of advanced diagnostic tools for accurate and efficient glucose tolerance testing.

Glucose Tolerance Test Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Glucose Tolerance Test Market- Competitive Landscape:

The market is propelled by growing awareness and efforts for early diabetes detection. Companies are prioritizing strategic collaborations to enhance research and develop advanced diagnostic solutions. To stay competitive, players are investing in cutting-edge technologies, like digital health integration, for better glucose monitoring. Additionally, expanding global presence through mergers and acquisitions is a key focus, as it helps diversify product lines and reach untapped markets, boosting their overall competitiveness and market influence.

Recent Developments:

In August 2024, DirectSens has introduced the XpressGT RUO kit for diagnosing conditions like Gestational Diabetes, Endometriosis, Insulin Resistance, and Liver Disease. Compatible with standard clinical analyzers, XpressGT provides results in just 8 minutes, measuring 2-hydroxybutyrate (2-HB) levels in venous blood, which, when elevated, indicate potential endocrine and metabolic disorders.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GLUCOSE TOLERANCE TEST MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Thermo Fisher Scientific Inc.
  • NIPRO
  • Medtronic
  • Thermo Fisher Scientific Inc.
  • NIPRO
  • Medtronic
  • Trividia Health, Inc.
  • Healius Limited
  • Dexcom, Inc.
  • Penlan Healthcare Ltd.
  • Johnson & Johnson Services, Inc.
  • Quest Diagnostics Incorporated
  • Abbott
  • Laboratory Corporation of America Holdings
  • Cleveland HeartLab, Inc.
  • ARUP Laboratories
  • Merck KGaA
  • Ascensia Diabetes Care Holdings AG
  • Bayer AG
  • E-Zlab Health Services
  • LifeScan IP Holdings, LLC
  • F. Hoffman-La Roche Ltd.
  • Sanofi
  • Others

GLOBAL GLUCOSE TOLERANCE TEST MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Blood Glucose Testing Kit
  • Smart Sensors
  • Test Slips
  • Meters
  • Others

GLOBAL GLUCOSE TOLERANCE TEST MARKET, BY DISEASE INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Diabetes Hypoglycemia
  • Reactive Hypoglycemia
  • Gestational Diabetes
  • Others

GLOBAL GLUCOSE TOLERANCE TEST MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Homecare Settings
  • Hospitals & Clinics
  • Diagnostic Centers
  • Others

GLOBAL GLUCOSE TOLERANCE TEST MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Glucose Tolerance Test Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Glucose Tolerance Test Market Snippet by Product Type
    • 2.1.2. Glucose Tolerance Test Market Snippet by Disease Indication
    • 2.1.3. Glucose Tolerance Test Market Snippet by End User
    • 2.1.4. Glucose Tolerance Test Market Snippet by Country
    • 2.1.5. Glucose Tolerance Test Market Snippet by Region
  • 2.2. Competitive Insights

3. Glucose Tolerance Test Key Market Trends

  • 3.1. Glucose Tolerance Test Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Glucose Tolerance Test Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Glucose Tolerance Test Market Opportunities
  • 3.4. Glucose Tolerance Test Market Future Trends

4. Glucose Tolerance Test Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Glucose Tolerance Test Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Glucose Tolerance Test Market Landscape

  • 6.1. Glucose Tolerance Test Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Glucose Tolerance Test Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Blood Glucose Testing Kit
    • 7.1.3. Smart Sensors
    • 7.1.4. Meters
    • 7.1.5. Others

8. Glucose Tolerance Test Market - By Disease Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Indication, 2023 & 2032 (%)
    • 8.1.2. Diabetes Hypoglycaemia
    • 8.1.3. Reactive Hypoglycaemia
    • 8.1.4. Gestational Diabetes
    • 8.1.5. Others

9. Glucose Tolerance Test Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Homecare Settings
    • 9.1.3. Hospitals & Clinics
    • 9.1.4. Diagnostic Centers
    • 9.1.5. Others

10. Glucose Tolerance Test Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Glucose Tolerance Test Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Glucose Tolerance Test Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Glucose Tolerance Test Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Glucose Tolerance Test Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Glucose Tolerance Test Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Glucose Tolerance Test Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific Inc.
    • 11.2.2. NIPRO
    • 11.2.3. Medtronic
    • 11.2.4. Trividia Health, Inc.
    • 11.2.5. Healius Limited
    • 11.2.6. Dexcom, Inc.
    • 11.2.7. Penlan Healthcare Ltd.
    • 11.2.8. Johnson & Johnson Services, Inc.
    • 11.2.9. Quest Diagnostics Incorporated
    • 11.2.10. Abbott
    • 11.2.11. Laboratory Corporation of America Holdings
    • 11.2.12. Cleveland HeartLab, Inc.
    • 11.2.13. ARUP Laboratories
    • 11.2.14. Merck KGaA
    • 11.2.15. Ascensia Diabetes Care Holdings AG
    • 11.2.16. Bayer AG
    • 11.2.17. E-Zlab Health Services
    • 11.2.18. LifeScan IP Holdings, LLC
    • 11.2.19. F. Hoffman-La Roche Ltd.
    • 11.2.20. Sanofi
    • 11.2.21. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us